CRIS Current Research Information System

DOMENICALI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.968
AS - Asia 9.436
EU - Europa 6.422
SA - Sud America 571
AF - Africa 451
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 26.879
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.816
VN - Vietnam 2.818
SG - Singapore 2.279
CN - Cina 2.126
IT - Italia 1.574
GB - Regno Unito 1.248
HK - Hong Kong 834
SE - Svezia 693
DE - Germania 677
FR - Francia 433
BR - Brasile 400
IN - India 356
RU - Federazione Russa 296
NL - Olanda 242
IE - Irlanda 229
UA - Ucraina 219
BD - Bangladesh 211
CH - Svizzera 194
KR - Corea 154
ZA - Sudafrica 145
JP - Giappone 140
TG - Togo 127
FI - Finlandia 108
BG - Bulgaria 100
EE - Estonia 94
CA - Canada 90
CI - Costa d'Avorio 87
JO - Giordania 77
AT - Austria 72
AR - Argentina 67
TH - Thailandia 67
ES - Italia 62
PH - Filippine 62
ID - Indonesia 45
IR - Iran 41
PL - Polonia 41
TR - Turchia 37
BE - Belgio 35
EC - Ecuador 35
MX - Messico 33
SC - Seychelles 29
CL - Cile 28
IQ - Iraq 28
PK - Pakistan 25
SA - Arabia Saudita 21
AU - Australia 20
GR - Grecia 20
TW - Taiwan 20
UZ - Uzbekistan 19
CO - Colombia 17
HR - Croazia 14
MY - Malesia 13
CZ - Repubblica Ceca 12
MA - Marocco 12
AE - Emirati Arabi Uniti 11
LB - Libano 11
LT - Lituania 11
RO - Romania 10
ET - Etiopia 9
IL - Israele 9
NG - Nigeria 9
TN - Tunisia 9
JM - Giamaica 7
PY - Paraguay 7
VE - Venezuela 7
EG - Egitto 6
TT - Trinidad e Tobago 6
NP - Nepal 5
PE - Perù 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
AZ - Azerbaigian 4
DK - Danimarca 4
DZ - Algeria 4
LV - Lettonia 4
MU - Mauritius 4
NO - Norvegia 4
XK - ???statistics.table.value.countryCode.XK??? 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GH - Ghana 3
HN - Honduras 3
HU - Ungheria 3
KZ - Kazakistan 3
LU - Lussemburgo 3
MN - Mongolia 3
OM - Oman 3
PS - Palestinian Territory 3
BO - Bolivia 2
EU - Europa 2
KE - Kenya 2
KG - Kirghizistan 2
KH - Cambogia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SI - Slovenia 2
SN - Senegal 2
UY - Uruguay 2
AL - Albania 1
Totale 26.855
Salva come PNG Salva come JPEG
Città #
Singapore 1.523
Southend 1.064
Ashburn 1.048
Fairfield 874
Hong Kong 779
Chandler 700
San Jose 608
Ho Chi Minh City 575
Hanoi 524
Santa Clara 516
Dong Ket 470
Woodbridge 445
Bologna 371
Seattle 371
Hefei 370
Houston 365
Wilmington 363
Cambridge 322
Princeton 273
Beijing 251
Boardman 245
Ann Arbor 236
Dublin 227
Los Angeles 194
Bern 178
Council Bluffs 177
Lauterbourg 150
Seoul 131
Jacksonville 126
Lomé 126
New York 121
Milan 120
Dallas 116
Nanjing 115
Tokyo 114
Westminster 107
Sofia 99
Padova 97
Da Nang 93
Abidjan 87
Berlin 81
Buffalo 77
Amman 76
Helsinki 75
Haiphong 72
Munich 66
Turin 65
Florence 64
San Diego 63
Shanghai 62
Jinan 60
Saint Petersburg 60
Shenyang 60
Guangzhou 53
Redondo Beach 51
São Paulo 51
Vienna 48
Frankfurt am Main 46
Changsha 44
Hebei 40
Bengaluru 39
Rome 39
Tianjin 39
Chicago 38
Hải Dương 34
Johannesburg 34
Amsterdam 33
London 33
Nuremberg 32
Brussels 31
Redmond 30
Bangkok 29
Dearborn 29
Mülheim 29
Nanchang 29
Paris 29
Orem 27
San Francisco 27
Biên Hòa 26
Can Tho 26
Phoenix 26
Toronto 26
Jakarta 24
Rimini 24
Warsaw 24
Falkenstein 23
Jiaxing 23
Medford 23
Montreal 23
Naples 23
Norwalk 23
Zhengzhou 23
Atlanta 22
Bremen 21
Hangzhou 21
Thái Nguyên 21
Brooklyn 20
Düsseldorf 20
Redwood City 20
Barcelona 19
Totale 16.967
Salva come PNG Salva come JPEG
Nome #
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals 307
Accesses for alcohol intoxication to the emergency department and the risk of re-hospitalization: An observational retrospective study 302
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 287
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 268
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 266
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 252
Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule. 250
A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis. 243
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 242
Ethical and legal implications of health monitoring wearable devices: A scoping review 241
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 238
A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection. 233
A novel model of CCl4-induced cirrosi with ascites in the mouse. 225
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 223
The nutritional status modulates preservation-reperfusion injury in rat fatty liver. 222
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma 221
A novel sodium overload test predicting ascites decompensation in rats with CCL4-induced cirrhosis. 221
Low haemoglobin level predicts early hospital readmission in patients with cirrhosis and acute decompensation 220
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 219
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 219
Oxidative injury in rat fatty liver exposed to ischemia-reperfusion is modulated by nutritional status. 216
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 216
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 212
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. 211
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 211
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis 209
Clinical indications for the albumin use: Still a controversial issue. 208
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 208
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 208
Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosis. 207
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study 206
Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET) 204
The reduced tolerance of rat fatty liver to ischemia-reperfusion is associated to mitochondrial oxidative injury. 203
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury 201
Mortality and its association with chronic alcohol-related diseases in patients admitted to the emergency department for acute alcoholic intoxication: retrospective cohort study 200
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 200
Metabolic disorders across hepatocellular carcinoma in Italy 200
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 196
A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field. 195
Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. 194
Posttranscriptional changes of serum albumin: clinical and prognostic meaning in hospitalized patients with cirrhosis. 194
C-type natriuretic peptide (CNP) favours natriuresis in pre-ascitic cirrhotic patients. 193
Daily profile of circulating c-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects. Relationship with renal function. 193
Portal vein arterialization for the treatment of post resection acute liver failure in the rat. 191
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 191
Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases. 190
Transthoracic electrical bioimpedance: a non-invasive technique for the evaluation of the hemodynamic alterations in patients with liver cirrhosis. 190
Could Inflammatory Indices and Metabolic Syndrome Predict the Risk of Cancer Development? Analysis from the Bagnacavallo Population Study 189
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. 188
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study. 188
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. 188
Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. 188
The endocannabinoid system and liver diseases. 184
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischemia-reperfusion injury complicated by endotoxemia. 184
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People 182
QT Interval Correction in Patients with Cirrhosis 181
Successful treatment of CCl4-induced acute liver failure with portal vein arterialization in the rat. 180
Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. 179
Effect of the cannabinoid CB1 receptor antagonist SR141716 in a rat model of liver inflammation 178
Predictors of clinical trajectories of patients with acutely decompensated cirrhosis. An external validation of the PREDICT study 177
Acute-on-chronic liver failure is a distinct syndrome developing in patients with acute dcompensation of cirrhosis. 176
QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis. 175
How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. 174
Development and validation of a scoring system that includes corrected QT interval for risk analysis of patients with cirrhosis and gastrointestinal bleeding 172
Dorsal acoustic windows may ameliorate liver ultrasound in patients with liver disease and meteorism/obesity/ascites. 171
Doxorubicin coupled to lactosaminated albumin: effects on rats with liver fibrosis and cirrhosis. 170
Real-world experience with long-term albumin in patients with cirrhosis and ascites 167
Portal vein arterialization increases liver regeneration in acute liver failure induced by extended hepatectomy or toxin administration in the rat 167
Simple and rapid LC-MS method for the determination of circulating albumin microheterogeneity in veal calves exposed to heat stress 167
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study 167
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. 166
Long-term beta-blockade shortens QT interval prolongation in patients with liver cirrhosis 166
Gioco responsabile e comportamenti di salute: un progetto di ricerca e intervento in Emilia-Romagna 166
null 164
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis. 164
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications 163
Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis. 162
Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation 160
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 159
Endocannabinoids and endocannabinoid-related molecules in patients with liver cirrhosis 158
Attitudes, barriers, and facilitators toward tools supporting appropriate prescribing among healthcare professionals: a cross-sectional study 157
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis 156
Increased anandamide-induced relaxation in mesenteric arteries of cirrhotic rats. Role of cannabinoid and vanilloid receptors. 156
A brief up-date of the use of sodium exybate for the treatment of alcohol use disorders. 156
Years of life that could be saved from prevention of hepatocellular carcinoma. 155
Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study. 153
L’apparato cardiovascolare dell’anziano. 152
Successful treatment of CCL4-induced acute liver failure with portal vein arterialization in the rat. 152
QT interval in patients with cirrhosis: failure of Bazett’s correction and identification of a disease-specific formula. 152
Wearable sensors for monitoring caregivers of people with dementia: a scoping review 151
Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population. 151
The renin-angiotensin-aldosterone system in cirrhosis. 150
Hyposplenism as a cause of pneumococcal meningoencephalitis in an adult patient with coeliac disease 150
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 150
The role of the circadian timing system in sarcopenia in old age: a scoping review 150
A web-based group treatment for patients with alcoholic liver diseases at the time of the COVID-19 pandemic 148
Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF) 146
Is there an association between commonly employed biomarkers of liver fibrosis and liver stiffness in the general population? 146
Mortality risk in a cohort of Italian alcoholic individuals treated for alcohol dependence. 145
Prevalence of and risk factors for fatty liver in the general population of Northern Italy: The Bagnacavallo Study 145
Totale 19.087
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.562
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.562
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021752 0 0 0 0 0 0 0 0 0 0 0 752
2021/20222.721 278 94 140 219 204 136 100 174 114 192 676 394
2022/20233.085 280 455 163 365 192 228 89 182 528 70 243 290
2023/20241.050 69 153 91 95 74 200 55 87 46 66 77 37
2024/20253.946 127 567 333 305 689 196 175 85 88 305 187 889
2025/202610.211 739 783 833 718 936 497 1.422 390 1.958 892 517 526
Totale 27.389